Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Shilpa Medicare Limited ( (IN:SHILPAMED) ) is now available.
Shilpa Medicare Limited has released its investor presentation for the quarter and nine months ended 31 December 2025, detailing a company overview, business highlights, financial performance and other corporate updates. The disclosure, made under regulatory requirements and available on the company’s website, is intended to inform shareholders and market participants about the firm’s recent operational and financial trajectory, reinforcing transparency and supporting investor assessment of its performance and positioning in the healthcare sector.
More about Shilpa Medicare Limited
Shilpa Medicare Limited is an Indian pharmaceutical company focused on innovating for affordable healthcare. Headquartered in Raichur, Karnataka, with a corporate and administrative office branded as “Shilpa House,” the company operates in the healthcare sector, providing medicines and related pharmaceutical products, and maintains listings on both BSE and NSE under the symbol SHILPAMED.
Average Trading Volume: 13,695
Technical Sentiment Signal: Hold
Current Market Cap: 61.08B INR
See more data about SHILPAMED stock on TipRanks’ Stock Analysis page.